348 related articles for article (PubMed ID: 26890737)
1. Puerarin Ameliorates D-Galactose Induced Enhanced Hippocampal Neurogenesis and Tau Hyperphosphorylation in Rat Brain.
Hong XP; Chen T; Yin NN; Han YM; Yuan F; Duan YJ; Shen F; Zhang YH; Chen ZB
J Alzheimers Dis; 2016; 51(2):605-17. PubMed ID: 26890737
[TBL] [Abstract][Full Text] [Related]
2. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3β/Nrf2 signaling pathway.
Zou Y; Hong B; Fan L; Zhou L; Liu Y; Wu Q; Zhang X; Dong M
Free Radic Res; 2013 Jan; 47(1):55-63. PubMed ID: 23088308
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
[TBL] [Abstract][Full Text] [Related]
5. Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo.
Li J; Wang G; Liu J; Zhou L; Dong M; Wang R; Li X; Li X; Lin C; Niu Y
Eur J Pharmacol; 2010 Dec; 649(1-3):195-201. PubMed ID: 20868658
[TBL] [Abstract][Full Text] [Related]
6. Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats.
Cai HY; Hölscher C; Yue XH; Zhang SX; Wang XH; Qiao F; Yang W; Qi JS
Neuroscience; 2014 Sep; 277():6-13. PubMed ID: 24583037
[TBL] [Abstract][Full Text] [Related]
7. Escitalopram Ameliorates Tau Hyperphosphorylation and Spatial Memory Deficits Induced by Protein Kinase A Activation in Sprague Dawley Rats.
Ren QG; Wang YJ; Gong WG; Xu L; Zhang ZJ
J Alzheimers Dis; 2015; 47(1):61-71. PubMed ID: 26402755
[TBL] [Abstract][Full Text] [Related]
8. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress with tau hyperphosphorylation in memory impaired 1,2-diacetylbenzene-treated mice.
Kang SW; Kim SJ; Kim MS
Toxicol Lett; 2017 Sep; 279():53-59. PubMed ID: 28734998
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model.
Guo Z; Chen Y; Mao YF; Zheng T; Jiang Y; Yan Y; Yin X; Zhang B
Sci Rep; 2017 Apr; 7():45971. PubMed ID: 28382978
[TBL] [Abstract][Full Text] [Related]
11. Acetyl-L-carnitine ameliorates spatial memory deficits induced by inhibition of phosphoinositol-3 kinase and protein kinase C.
Jiang X; Tian Q; Wang Y; Zhou XW; Xie JZ; Wang JZ; Zhu LQ
J Neurochem; 2011 Sep; 118(5):864-78. PubMed ID: 21689104
[TBL] [Abstract][Full Text] [Related]
12. Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway.
Hoppe JB; Coradini K; Frozza RL; Oliveira CM; Meneghetti AB; Bernardi A; Pires ES; Beck RC; Salbego CG
Neurobiol Learn Mem; 2013 Nov; 106():134-44. PubMed ID: 23954730
[TBL] [Abstract][Full Text] [Related]
13. Essential role of tau phosphorylation in adult hippocampal neurogenesis.
Hong XP; Peng CX; Wei W; Tian Q; Liu YH; Yao XQ; Zhang Y; Cao FY; Wang Q; Wang JZ
Hippocampus; 2010 Dec; 20(12):1339-49. PubMed ID: 19816983
[TBL] [Abstract][Full Text] [Related]
14. Dehydroevodiamine attenuates tau hyperphosphorylation and spatial memory deficit induced by activation of glycogen synthase kinase-3 in rats.
Peng JH; Zhang CE; Wei W; Hong XP; Pan XP; Wang JZ
Neuropharmacology; 2007 Jun; 52(7):1521-7. PubMed ID: 17434540
[TBL] [Abstract][Full Text] [Related]
15. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
Song G; Zhang Z; Wen L; Chen C; Shi Q; Zhang Y; Ni J; Liu Q
J Alzheimers Dis; 2014; 41(1):85-99. PubMed ID: 24577479
[TBL] [Abstract][Full Text] [Related]
16. Flupirtine attenuates chronic restraint stress-induced cognitive deficits and hippocampal apoptosis in male mice.
Huang P; Li C; Fu T; Zhao D; Yi Z; Lu Q; Guo L; Xu X
Behav Brain Res; 2015 Jul; 288():1-10. PubMed ID: 25869780
[TBL] [Abstract][Full Text] [Related]
17. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
Ali T; Kim MO
J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of lithium treatment for spatial memory deficits induced by tau hyperphosphorylation in splenectomized rats.
Tan WF; Cao XZ; Wang JK; Lv HW; Wu BY; Ma H
Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):1010-5. PubMed ID: 20659131
[TBL] [Abstract][Full Text] [Related]
19. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory.
Liu SJ; Zhang AH; Li HL; Wang Q; Deng HM; Netzer WJ; Xu H; Wang JZ
J Neurochem; 2003 Dec; 87(6):1333-44. PubMed ID: 14713290
[TBL] [Abstract][Full Text] [Related]
20. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
